X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22627) 22627
Publication (1378) 1378
Newsletter (391) 391
Magazine Article (113) 113
Book Review (99) 99
Book Chapter (59) 59
Dissertation (34) 34
Conference Proceeding (18) 18
Web Resource (15) 15
Newspaper Article (13) 13
Trade Publication Article (4) 4
Book / eBook (3) 3
Government Document (3) 3
Paper (3) 3
Data Set (2) 2
Streaming Video (2) 2
Archival Material (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12605) 12605
isoniazid (8986) 8986
tuberculosis (7096) 7096
isoniazid - therapeutic use (5817) 5817
male (5788) 5788
female (5280) 5280
adult (4403) 4403
isoniazid - pharmacology (3660) 3660
middle aged (3178) 3178
index medicus (3107) 3107
animals (3032) 3032
tuberculosis, pulmonary - drug therapy (2999) 2999
antitubercular agents - therapeutic use (2861) 2861
mycobacterium tuberculosis - drug effects (2850) 2850
rifampin - therapeutic use (2323) 2323
isoniazid - administration & dosage (2313) 2313
niacin (2306) 2306
adolescent (2161) 2161
isoniazid - adverse effects (1994) 1994
infectious diseases (1887) 1887
drug therapy, combination (1824) 1824
tuberculosis - drug therapy (1811) 1811
antitubercular agents - pharmacology (1805) 1805
child (1778) 1778
aged (1774) 1774
mycobacterium tuberculosis (1514) 1514
rifampin (1502) 1502
streptomycin - therapeutic use (1457) 1457
microbiology (1426) 1426
drug resistance, microbial (1368) 1368
drug resistance (1322) 1322
time factors (1297) 1297
pharmacology & pharmacy (1275) 1275
antitubercular agents - administration & dosage (1265) 1265
respiratory system (1263) 1263
nicotinic acids - therapeutic use (1211) 1211
ethambutol - therapeutic use (1192) 1192
research (1183) 1183
rifampin - administration & dosage (1181) 1181
isomerism (1168) 1168
mycobacterium tuberculosis - isolation & purification (1127) 1127
rifampin - pharmacology (1126) 1126
microbial sensitivity tests (1069) 1069
mice (1055) 1055
mycobacterium-tuberculosis (1030) 1030
mycobacterium tuberculosis - genetics (991) 991
drug therapy (988) 988
infant (982) 982
pyrazinamide - therapeutic use (933) 933
tuberculosis - prevention & control (918) 918
rats (910) 910
child, preschool (905) 905
antitubercular agents - adverse effects (900) 900
antitubercular agents (882) 882
pyrazinamide (877) 877
streptomycin (873) 873
rifampicin (863) 863
tuberculosis, pulmonary - therapy (856) 856
isoniazid - metabolism (807) 807
treatment outcome (789) 789
medicine, general & internal (780) 780
risk factors (780) 780
tuberculin test (769) 769
mutation (752) 752
pulmonary tuberculosis (748) 748
streptomycin - pharmacology (743) 743
immunology (707) 707
isoniazid - analogs & derivatives (700) 700
research article (699) 699
nicotinic acids - pharmacology (679) 679
drugs (671) 671
tuberculosis, pulmonary - microbiology (666) 666
analysis (652) 652
tuberculosis, pulmonary (646) 646
rifampin - adverse effects (622) 622
diagnosis (615) 615
aminosalicylic acids - therapeutic use (603) 603
guinea pigs (588) 588
tuberculosis, pulmonary - prevention & control (586) 586
tuberculosis - epidemiology (583) 583
tuberculosis, multidrug-resistant - drug therapy (581) 581
aminosalicylic acids (580) 580
isoniazid - toxicity (574) 574
ethambutol (571) 571
health aspects (571) 571
hiv (569) 569
sputum - microbiology (567) 567
aminosalicylic acid (554) 554
bacterial infections and mycoses (550) 550
ethambutol - administration & dosage (540) 540
follow-up studies (529) 529
pyrazinamide - administration & dosage (521) 521
streptomycin - administration & dosage (518) 518
young adult (512) 512
retrospective studies (503) 503
isoniazid - blood (502) 502
medicine (497) 497
isoniazid resistance (496) 496
infection (493) 493
tuberculosis - microbiology (491) 491
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16768) 16768
French (1246) 1246
Russian (1185) 1185
German (1115) 1115
Italian (689) 689
Japanese (555) 555
Spanish (552) 552
Polish (358) 358
Chinese (140) 140
Portuguese (119) 119
Hungarian (80) 80
Romanian (65) 65
Dutch (62) 62
Turkish (47) 47
Czech (42) 42
Korean (40) 40
Norwegian (31) 31
Ukrainian (27) 27
Swedish (26) 26
Bulgarian (24) 24
Danish (18) 18
Croatian (15) 15
Hebrew (13) 13
Serbian (10) 10
Finnish (9) 9
Slovak (5) 5
Persian (3) 3
Greek (2) 2
Indonesian (2) 2
Lithuanian (2) 2
Albanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Tuberculosis and Lung Disease, ISSN 1027-3719, 01/2013, Volume 17, Issue 1, pp. 125 - 128
SETTING: The Mycobacteria Group of the National Reference Laboratory, National Laboratory Network, National Institute of Health and the Public Health... 
Isoniazid
Journal Article
Der Pneumologe, ISSN 1613-5636, 06/2013, Volume 10, Issue 1, p. 39
Trotz erheblicher Fortschritte in den vergangenen 10 Jahren ist die Tuberkulose (TB) mit geschatzten 8,7 Mio. neuer Falle im Jahr 2011 und 1,4 Mio. Todesfallen... 
Isoniazid
Journal Article
Sensors & Actuators: B. Chemical, ISSN 0925-4005, 09/2015, Volume 216, p. 402
Schematic illustration of INA-cit-AgNPs based colorimetric detection of Cr.sup.3+. 
Sensors | Isoniazid
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 1, pp. 11 - 20
In this study in South Africa, 1148 HIV-infected adults with TB were assigned to rifapentine–isoniazid weekly for 12 weeks, rifampin–isoniazid twice weekly for... 
TWICE | MEDICINE, GENERAL & INTERNAL | DOSE PHARMACOKINETICS | THERAPY | LATENT TUBERCULOSIS | RIFAPENTINE | RIFAMPICIN | ISONIAZID PROPHYLAXIS | Rifampin - analogs & derivatives | Antitubercular Agents - adverse effects | Follow-Up Studies | Humans | Isoniazid - adverse effects | Drug Resistance, Bacterial | Male | Risk | Mycobacterium tuberculosis - drug effects | Cause of Death | Rifampin - adverse effects | Adult | Female | HIV Infections - mortality | Rifampin - administration & dosage | Drug Therapy, Combination | Anti-Retroviral Agents - therapeutic use | Tuberculosis, Multidrug-Resistant | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Isoniazid - administration & dosage | AIDS-Related Opportunistic Infections - prevention & control | Tuberculosis - prevention & control | Antitubercular Agents - administration & dosage | HIV Infections - drug therapy | Patient Compliance | Prevention | Control | Medical examination | Tuberculosis | South Africans | Causes of | Dosage and administration | Drug therapy | HIV infection | Isoniazid | Rifampin | Rifapentine | Antiretroviral drugs | Hypersensitivity | Multidrug resistance | Infections | Tuberculin | Drug resistance | Patients | Antiretroviral therapy | CD4 antigen | Infectious diseases | Womens health | Biopsy | Human immunodeficiency virus--HIV | Skin tests
Journal Article
JAMA Pediatrics, ISSN 2168-6203, 03/2015, Volume 169, Issue 3, pp. 247 - 255
Journal Article
Journal Article
by Danel, Christine and Moh, Raoul and Gabillard, Delphine and Badje, Anani and Le Carrou, Jérôme and Ouassa, Timothée and Ouattara, Eric and Anzian, Amani and Ntakpé, Jean-Baptiste and Minga, Albert and Kouame, Gérard M and Bouhoussou, Franck and Emieme, Arlette and Kouamé, Antoine and Inwoley, André and Toni, Thomas-D'Aquin and Ahiboh, Hugues and Kabran, Mathieu and Rabe, Cyprien and Sidibé, Baba and Nzunetu, Gustave and Konan, Romuald and Gnokoro, Joachim and Gouesse, Patrice and Messou, Eugène and Dohoun, Lambert and Kamagate, Synali and Yao, Abo and Amon, Solange and Kouame, Amadou-Barenson and Koua, Aboli and Kouamé, Emmanuel and Ndri, Yao and Ba-Gomis, Olivier and Daligou, Marcelle and Ackoundzé, Simplice and Hawerlander, Denise and Ani, Alex and Dembéle, Fassery and Koné, Fatoumata and Guéhi, Calixte and Kanga, Constance and Koule, Serge and Séri, Jonas and Oyebi, Mykayila and Mbakop, Nathalie and Makaila, Olewole and Babatunde, Carole and Babatounde, Nathanael and Bleoué, Gisèle and Tchoutedjem, Mireille and Kouadio, Alain-Claude and Sena, Ghislaine and Yededji, Sahinou-Yediga and Assi, Rodrigue and Bakayoko, Alima and Mahassadi, Alassane and Attia, Alain and Oussou, Armel and Mobio, Max and Bamba, Doféré and Koman, Mesmin and Horo, Apollinaire and Deschamps, Nina and Chenal, Henri and Sassan-Morokro, Madeleine and Konate, Seidou and Aka, Kakou and Aoussi, Eba and Journot, Valérie and Nchot, Célestin and Karcher, Sophie and Chaix, Marie-Laure and Rouzioux, Christine and Sow, Papa-Salif and Perronne, Christian and Girard, Pierre-Marie and Menan, Hervé and Bissagnene, Emmanuel and Kadio, Auguste and Ettiegne-Traore, Virginie and Moh-Semdé, Corinne and Kouame, Abo and Massumbuko, Jean-Marie and Chêne, Geneviève and Dosso, Mireille and Domoua, Serge K and N'Dri-Yoman, Thérèse and Salamon, Roger and Eholié, Serge P and Anglaret, Xavier and The TEMPRANO ANRS 12136 Study Group and TEMPRANO ANRS 12136 Study Group
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 9, pp. 808 - 822
Journal Article
07/2009
The most frequent mutations associated with rifampin and isoniazid resistance in Mycobacterium are the substitutions at codons 531 and 315 in the rpoB and katG... 
tuberculosis - rifampin - isoniazid - mutations
Web Resource
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2012, Volume 56, Issue 5, pp. 2535 - 2545
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 23, pp. 2155 - 2166
Journal Article